| Code | 80760 | ||||||||||
| MA number | 44/0590/09-S | ||||||||||
| Product Form: | con inf 1x10 ml/50 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 12.10.2009 |
| SPC: |
SPC_Oxaliplatin Kabi 5 mg_ml_11.2022.pdf
|
| PIL: |
PIL_Oxaliplatin Kabi 5 mg_ml_11.2022.pdf
|
| Safety feature | Yes |
| Data update: | 30.05.2018 |
